Académique Documents
Professionnel Documents
Culture Documents
HYDROGEL
ABSTRACT
Present study deals with the development and characterization of aloe vera cosmetic herbal
hydrogel preparation using inner part of aloe vera leaf, acacia, hydroxy propyl methyl cellulose
(HPMC), carbopol 934, glycerine, tartaric acid, potassium sorbate and sodium benzoate. Aloe
vera liquid was prepared by heating at low temperature and the hydrogel was prepared by simple
dissolving method of other ingredients in a specific manner. Four formulations were developed
which differ in the ratio of hydrogel forming polymers. Formulation A1, A2, A3 and A4 were
composed of acacia, HPMC, carbopol 934 in the ratio of 1:1:1, 1:2:1, 2:1:1 and 1:1:2
respectively. All the formulations were evaluated for percentage moisture content, transparency.
INTRODUCTION
Aloe vera is an important medicinal plant. It has larger demands and is traded in medicinal drug
markets of the world for flavouring liquid and a source of aloin (4.5 to 25 per cent). In more
traditional uses, physicians use aloe vera-based creams to heal serious thermal injuries, such as
burns and frostbite. Dentists employ aloe vera gels to reduce swelling and inflammation of the
gums. Dermatologists rely on aloe vera products to help clear acne, and optometrists find the
products helpful in soothing eye inflammations. Professional sports trainers treat their athletes
muscle aches and sprains, skin abrasions, and blisters with aloe vera. Cosmetics companies, for
its beneficial effect of aloe Vera, incorporate it into, cosmetic and skin care products. It is also for
the marketing appeal the words made with aloe attract the consumer. Drinking aloe vera with
honey is said to have the therapeutic effects on arthritis, ulcers, diabetes, and other health
conditions. The wide range of applications, and the beneficial effects of its use, continues to
increase the popularity of this ancient plant.Aloevera is a perennial, drought-resisting, succulent
plant belonging to the Lily (Liliaceae) family which, historically, has been used for a variety of
medicinal purposes. The plant has stiff grey-green lanceshaped leaves containing clear gel in a
central mucilaginous pulp. Clinical evaluations have revealed that the pharmacological active
ingredients are concentrated in both the gel and rind of the aloe vera leaves. These active
ingredients have been shown to have analgesic and anti-inflammatory effects. The true aloe vera
plant is called Aloe barbadensis Miller, otherwise called the Curacao aloe, and is the most
medicinally potent of the 300 (and more) varieties found around the world. Most people in the
UK today know of aloe vera because of its inclusion in many popular cosmetic products. Over
the years, the plant has been known by a number of names such as the wand of heaven,
heavens blessing and the silent healer.Number of aloe vera herbal formulations available in
the form of cream, gel, facial solution, moisturizer etc, while these formulations contain very less
quantity of aloe vera extract and herbal component. These formulations may also contain toxic
ingredients such as surfactant. Present investigation deals with the development of aloe vera
cosmetic
Master formula
Table 1: Composition of aloe vera herbal hydrogel formulations A1 to A4
Ingredients
Aleovera ml
A1
75
Acacia gm
A2
A3
75
0.5
A4
75
0.375
75
0.375 0.75
HPMC gm
0.5 0.75
0.375
Carbopol 934 gm
Glycerine ml
0.375
0.75
5
Ascorbic acid
Albumin
Tartaric acid gm
1.5
1.5
0.5
1.5
1.5
0.5 0.5
0.5
Heating
Liquid concentrate
+
glycerin, potassium
sorbate ,
Tartaric acid
MONOGRAPHS
Acacia
DEFINITION
Air-hardened, gummy exudate flowing naturally from or obtained by incision of the trunk and branches of Acacia.
CHARACTERS
Acacia is almost completely but very slowly soluble, after about 2 h, in twice its mass of water leaving only a very small
residue of vegetable particles; the liquid obtained is colourless or yellowish, dense, viscous, adhesive, translucent and weakly
acid to blue litmus paper. Acacia is practically insoluble in ethanol (96 percent).
IDENTIFICATIOn
A. Acacia occurs as yellowish-white, yellow or pale amber, sometimes with a pinkish tint, friable, opaque, spheroidal, oval or
reniform pieces (tears) of a diameter from about 1-3 cm, frequently with a cracked surface, easily broken into irregular, whitish
or slightly yellowish angular fragments with conchoidal fracture and a glassy and transparent appearance. In the centre of an
unbroken tear there is sometimes a small cavity.
B. Reduce to a powder (355) (2.9.12). The powder is white or yellowish-white. Examine under a microscope using a 50 per cent
V/V solution of glycerol R. The powder shows the following diagnostic characters: angular, irregular, colourless, transparent
fragments. Only traces of starch or vegetable tissues are visible. No stratified membrane is apparent.
TESTS
Solutions
Dissolve 3.0 g of the powdered drug (355) (2.9.12) in 25 mL of water R by stirring for 30 min. Allow to stand for 30 min and
dilute to 30 mL with water R.
Insoluble matter
Maximum 0.5 per cent.
To 5.0 g of the powdered drug (355) (2.9.12) add 100 mL of water R and 14 mL of dilute hydrochloric acid R, boil gently for 15
min, shaking frequently and filter while hot through a tared sintered-glass filter (2.1.2). Wash with hot water R and dry at 100105 C. The residue weighs a maximum of 25 mg.
Glucose and fructose
Thin-layer chromatography (2.2.27).
Test solutionTo 0.100 g of the powdered drug (355) (2.9.12) in a thick-walled centrifuge tube add 2 mL of a 100 g/L solution
of trifluoroacetic acid R, shake vigorously to dissolve the forming gel, stopper the tube and heat the mixture at 120 C for 1 h.
Centrifuge the hydrolysate, transfer the clear supernatant carefully into a 50 mL flask, add 10 mL of water R and evaporate the
solution to dryness under reduced pressure. To the resulting clear film add 0.1 mL of water R and 0.9 mL of methanol R.
Centrifuge to separate the amorphous precipitate. Dilute the supernatant, if necessary, to 1 mL with methanol R.
Reference solution:
Dissolve 10 mg of arabinose R, 10 mg of galactose R, 10 mg of glucose R, 10 mg of rhamnose R and 10 mg of xylose R in 1 mL
of water R and dilute to 10 mL with methanol R.
Ascorbic acid
DEFINITION
(5R)-5-[(1S)-1,2-Dihydroxyethyl]-3,4-dihydroxyfuran-2(5H)-one.
Content
99.0 per cent to 100.5 per cent.
CHARACTERS
Appearance
White or almost white, crystalline powder or colourless crystals, becoming discoloured on exposure to air and moisture.
Solubility
Freely soluble in water, sparingly soluble in ethanol (96 per cent).
MP
About 190 C, with decomposition.
IDENTIFICATION
First identificationB, C.
Second identificationA, C, D
A. Ultraviolet and visible absorption spectrophotometry (2.2.25).
Test solutionDissolve 0.10 g in water R and dilute immediately to 100.0 mL with the same solvent. Add 1.0 mL of this solution to 10 mL of
0.1 M hydrochloric acid and dilute to 100.0 mL with water R.
Absorption maximumAt 243 nm, determined immediately after dissolution.
Specific absorbance at the absorption maximum545 to 585.
B. Infrared absorption spectrophotometry (2.2.24).
Comparisonascorbic acid CRS.
C. pH (2.2.3): 2.1 to 2.6 for solution S (see Tests).
D. To 1 mL of solution S add 0.2 mL of dilute nitric acid R and 0.2 mL of silver nitrate solution R2. A grey precipitate is formed.
TESTS
Solution S
Dissolve 1.0 g in carbon dioxide-free water R and dilute to 20 mL with the same solvent.
Appearance of solution
Solution S is clear (2.2.1) and not more intensely coloured than reference solution BY7 (2.2.2, Method II).
Specific optical rotation (2.2.7) + 20.5 to + 21.5.
Dissolve 2.50 g in water R and dilute to 25.0 mL with the same solvent.
Impurity E
Maximum 0.2 per cent.
Test solutionDissolve 0.25 g in 5 mL of water R. Neutralise using dilute sodium hydroxide solution R and add 1 mL of dilute acetic acid R and
0.5 mL of calcium chloride solution R.
Reference solutionDissolve 70 mg of oxalic acid R in water R and dilute to 500 mL with the same solvent; to 5 mL of this solution add 1 mL
of dilute acetic acid R and 0.5 mL of calcium chloride solution R.
Allow the solutions to stand for 1 h. Any opalescence in the test solution is not more intense than that in the reference solution.
Related substances
Tartaric acid
DEFINITION
(2R,3R)-2,3-Dihydroxybutanedioic acid.
Content
99.5 per cent to 101.0 per cent (dried substance).
CHARACTERS
Appearance
White or almost white, crystalline powder or colourless crystals.
Solubility
Very soluble in water, freely soluble in ethanol (96 per cent).
IDENTIFICATION
A. Solution S (see Tests) is strongly acid (2.2.4).
B. It gives the reactions of tartrates (2.3.1).
TESTS
Solution S
Dissolve 5.0 g in distilled water R and dilute to 50 mL with the same solvent.
Appearance of solution
Solution S is clear (2.2.1) and not more intensely coloured than reference solution Y6 (2.2.2, Method II).
Specific optical rotation (2.2.7)
+ 12.0 to + 12.8 (dried substance).
Dissolve 5.00 g in water R and dilute to 25.0 mL with the same solvent.
ASSAY
Dissolve 0.650 g in 25 mL of water R. Titrate with 1 M sodium hydroxide using 0.5 mL of phenolphthalein solution R as indicator, until a pink
colour is obtained.
1 mL of 1 M sodium hydroxide is equivalent to 75.05 mg of C4H6O6.
DEFINITION
Potassium (E,E)-hexa-2,4-dienoate.
Content
99.0 per cent to 101.0 per cent (dried substance).
CHARACTERS
Appearance
White or almost white powder or granules.
Solubility
Very soluble in water, slightly soluble in ethanol (96 per cent).
IDENTIFICATION
First identificationB, D.
Second identificationA, C, D.
A. Ultraviolet and visible absorption spectrophotometry (2.2.25).
Test solutionDissolve 50.0 mg in water R and dilute to 250.0 mL with the same solvent. Dilute 2.0 mL of this solution to 200.0 mL with 0.1 M
hydrochloric acid .
Spectral range230-350 nm.
Absorption maximumAt 264 nm.
Specific absorbance at the absorption maximum1650 to 1900.
B. Infrared absorption spectrophotometry (2.2.24).
Comparisonpotassium sorbate CRS.
TESTS
Solution S
Dissolve 2.5 g in carbon dioxide-free water R and dilute to 50 mL with the same solvent.
Appearance of solution
Solution S is clear (2.2.1) and not more intensely coloured than reference solution Y5 (2.2.2, Method II).
Loss on drying (2.2.32)
Maximum 1.0 per cent, determined on 1.000 g by drying in an oven at 105 C for 3 h.
ASSAY
Dissolve 0.120 g in 20 mL of anhydrous acetic acid R. Titrate with 0.1 M perchloric acid using 0.1 mL of crystal violet solution R as indicator
until the colour changes from violet to bluish-green.
1 mL of 0.1 M perchloricacid is equivalent to 15.02 mg of C6H7KO2.
Sodium benzoate
DEFINITION
Sodium benzenecarboxylate.
Content
99.0 per cent to 100.5 per cent (dried substance).
CHARACTERS
Appearance
White or almost white, crystalline or granular powder or flakes, slightly hygroscopic.
Solubility
Freely soluble in water, sparingly soluble in ethanol (90 per cent V/V).
IDENTIFICATION
A. It gives reactions (b) and (c) of benzoates (2.3.1).
B. It gives reaction (a) of sodium (2.3.1).
TESTS
Solution S
Dissolve 10.0 g in carbon dioxide-free water R and dilute to 100 mL with the same solvent.
Appearance of solution
Solution S is clear (2.2.1) and not more intensely coloured than reference solution Y6 (2.2.2, Method II).
Acidity or alkalinity
To 10 mL of solution S add 10 mL of carbon dioxide-free water R and 0.2 mL of phenolphthalein solution R. Not more than 0.2 mL of 0.1 M
sodium hydroxide or 0.1 M hydrochloric acid is required to change the colour of the indicator.
Halogenated compounds
Maximum 200 ppm for ionised chlorine and maximum 300 ppm for total chlorine.
All glassware used must be chloride-free and may be prepared by soaking overnight in a 500 g/L solution of nitric acid R, rinsed with water R
and stored full of water R. It is recommended that glassware be reserved exclusively for this test.
Test solutionTo 20.0 mL of solution S add 5 mL of water R and dilute to 50.0 mL with ethanol (96 per cent) R.
Loss on drying (2.2.32)
Maximum 2.0 per cent, determined on 1.00 g by drying in an oven at 105 C.
ASSAY
Dissolve 0.250 g in 20 mL of anhydrous acetic acid R, heating to 50 C if necessary. Cool. Using 0.05 mL of naphtholbenzein solution R as
indicator, titrate with 0.1 M perchloric acid until a green colour is obtained.
Aloevera
Aloe is the dried latex of the leaves of Aloe barbadensis Miller (Aloe veraLinn), known in commerce as Curaao Aloe, or of Aloe ferox Miller
and hybrids of this species with Aloe africana Miller and Aloe spicata Baker, known in commerce as Cape Aloe (Fam. Liliaceae).
Identification
C: To 5 mL of the filtrate obtained in Identification test B add 2 mL of nitric acid: the mixture exhibits a reddish orange color with Curaao Aloe,
and a reddish brown color which changes rapidly to green with Cape Aloe.
Total ash
561
921
: not more than 4.0%.
: not more than 12.0%, determined by drying at 105
Cape Aloe Dusky to dark brown irregular masses, the surfaces of which are often covered with a yellowish powder. Its fracture is smooth and
glassy.
Powdered Aloe Yellow, yellowish brown to olive-brown in color. When mounted in a bland expressed oil, it appears as greenish yellow to
reddish brown angular or irregular fragments, the hues of which depend to some extent upon the thickness of the fragments.
A: Powdered Aloe dissolves in nitric acid with effervescence, forming a reddish brown to brown or green solution.
B: Intimately mix in a flask or bottle 1 g of finely powdered Aloe with 25 mL of cold water, shake the mixture occasionally during 2 hours,
transfer to a filter, and wash the filter and residue with sufficient cold water to make the filtrate measure 100 mL: the color of the filtrate, viewed
in the bulb of a 100-mL volumetric flask, is dark orange with Curaao Aloe, and greenish yellow with Cape Aloe. The filtrate darkens on
standing.
Assay
Macerate about 2 g of Aloe, accurately weighed, in about 70 mL of water in a suitable flask. Shake the mixture during 8 hours at 30-minute
intervals, and allow it to stand for 16 hours without shaking. Filter, and wash the flask and residue with small portions of water, passing the
washings through the filter, until the filtrate measures 100.0 mL. Evaporate a 50-mL aliquot of the filtrate in a tared dish on a steam bath to
dryness, and dry at 110 to constant weight. The weight of water-soluble extractive so obtained is not less than 50.0% of the weight of Aloe taken.
PACKEGING TEST
Containers Containers, including the closures, for ophthalmic ointments do not interact
physically or chemically with the preparation in any manner to alter the strength, quality, or
purity beyond the official requirements under the ordinary or customary conditions of handling,
shipment, storage, sale, and use.
Metal Particles Follow the Procedure set forth under Metal Particles in Ophthalmic
Ointments 751.
Leakage Select 10 tubes of the Ointment, with seals applied when specified. Thoroughly clean
and dry the exterior surfaces of each tube with an absorbent cloth. Place the tubes in a horizontal
position on a sheet of absorbent blotting paper in an oven maintained at a temperature of 60 3
for 8 hours. No significant leakage occurs during or at the completion of the test (disregard traces
of ointment presumed to originate externally from within the crimp of the tube or from the thread
of the cap). If leakage is observed from one, but not more than one, of the tubes, repeat the test
with 20 additional tubes of the Ointment. The requirement is met if no leakage is observed from
the first10 tubes tested, or if leakage is observed from not more than one of 30 tubes .
pH
pH = pHs + (E E S ) / k
BUFFER SOLUTIONS FOR STANDARDIZATION OF THE PH METER
Buffer Solutions for Standardization are to be prepared as directed in the accompanying table. *
Buffer salts of requisite purity can be obtained from the National Institute of Science.
For compendial purposes, pH is defined as the value given by a suitable, properly standardized,
potentiometric instrument (pH meter) capable of reproducing pH values to 0.02 pH unit using an
indicator electrode sensitive to hydrogen-ion activity, the glass electrode, and a suitable reference
electrode. The instrument should be capable of sensing the potential across the electrode pair
and, for pH standardization purposes, applying an adjustable potential to the circuit by
manipulation of standardization, zero, asymmetry, or calibration control, and should be
able to control the change in millivolts per unit change in pH reading through a temperature
and/or slope control. Measurements are made at 25 2, unless otherwise specified in the
individual monograph or herein.
in which E and E S are the measured potentials where the galvanic cell contains the solution
under test, represented by pH, and the appropriate Buffer Solution for Standardization,
represented by pHs, respectively. The value of k is the change in potential per unit change in pH
and is theoretically [0.05916 + 0.000198(t 25)] volts at any temperature t.
It should be emphasized that the definitions of pH, the pH scale, and the values assigned to the
Buffer Solutions for Standardization are for the purpose of establishing a practical, operational
system so that results may be compared between laboratories. The pH values thus measured do
not correspond exactly to those obtained by the definition, pH = log a H + . So long as the
solution being measured is sufficiently similar in composition to the buffer used for
standardization, the operational pH corresponds fairly closely to the theoretical pH. Although no
claim is made with respect to the suitability of the system for measuring hydrogen-ion activity or
concentration, the values obtained are closely related to the activity of the hydrogen-ion in
aqueous solutions.
Where a pH meter is standardized by use of an aqueous buffer and then used to measure the
pH of a nonaqueous solution or suspension, the ionization constant of the acid or base, the
dielectric constant of the medium, the liquid-junction potential (which may give rise to errors of
approximately 1 pH unit), and the hydrogen-ion response of the glass electrode are all changed.
For these reasons, the values so obtained with solutions that are only partially aqueous in
character can be regarded only as apparent pH values.
Technology. Solutions may be stored in hard glass or polyethylene bottles fitted with a tight
closure or carbon dioxide-absorbing tube (soda lime). Fresh solutions should be prepared at
intervals not to exceed 3 months using carbon dioxide-free water. The table indicates the pH of
the buffer solutions as a function of temperature. The instructions presented here are for the
preparation of solutions having the designated molal (m) concentrations. For convenience, and to
facilitate their preparation, however, instructions are given in terms of dilution to a 1000-mL
volume rather than specifying the use of 1000 g of solvent, which is the basis of the molality
system of solution concentration. The indicated quantities cannot be computed simply without
additional information.
VISCOSITY
Viscosity is a property of liquids that is closely related to the resistance to flow. It is defined in
terms of the force required to move one plane surface continuously past another under specified
steady-state conditions when the space between is filled by the liquid in question. It is defined as
the shear stress divided by the rate of shear strain. The basic unit is the poise; however,
viscosities commonly encountered represent fractions of the poise, so that the centipoise (1 poise
= 100 centipoises) proves to be the more convenient unit. The specifying of temperature is
capillary tube to the level of the top graduation line. Open both the vent and capillary tubes in
order to permit the liquid to flow into the reservoir against atmospheric pressure. [NOTE
Failure to open the vent tube before releasing the capillary tube will yield false values.] Record
the time, in seconds, for the liquid to flow from the upper mark to the lower mark in the capillary
tube.
Calculate the viscosimeter constant, k, from the equation:
k=v/dt
in which v is the known viscosity of the liquid in centipoises, d is the specific gravity of the
liquid tested at 20/20, and t is the time in seconds for the liquid to pass from the upper mark to
the lower mark.
UNIFORMITY OF DOSAGE UNITS
The test for Weight Variation is applicable for the following dosage forms:
To ensure the consistency of dosage units, each unit in a batch should have a drug substance
content within a narrow range around the label claim. Dosage units are defined as dosage forms
containing a single dose or a part of a dose of drug substance in each unit.
The term uniformity of dosage unit is defined as the degree of uniformity in the amount of the
drug substance among dosage units. Therefore, the requirements of this chapter apply to each
drug substance being comprised in dosage units containing one or more drug substances, unless
otherwise specified in the individual monograph.
The uniformity of dosage units can be demonstrated by either of two methods, Content
Uniformity or Weight Variation.
solids (including sterile solids) that are packaged in single-unit containers and that contain active
or inactive added substances, except that the test for Weight Variation may be applied in the
special situations stated in (W2) and (W3) below.
(W3)solids (including sterile solids) that are packaged in single-unit containers, with or without
added substances, whether active or inactive, that have been prepared from true solutions and
freeze-dried in the final containers and are labeled to indicate this method of preparation
CONTENT UNIFORMITY
Select not fewer than 30 units, and proceed as follows for the dosage form designated. Where the
amount of drug substance in a single dosage unit differs from that required in the Assay, adjust
the degree of dilution of the solutions and/or the volume of aliquots so that the concentration of
the drug substances in the final solution is of the same order as that obtained in the Assay
procedure; or, in the case of a titrimetric assay, use a titrant of a different concentration, if
necessary, so that an adequate volume of titrant is required (see Titrimetry 541); see also
Procedures under Tests and Assays in the General Notices and Requirements. If any such
modifications are made in the Assay procedure set forth in the individual monograph, make the
appropriate corresponding changes in the calculation formula and titration factor.
1.Prepare a composite specimen of a sufficient number of dosage units to provide the amount of
specimen called for in the Assay in the individual monograph plus the amount required for the
special Procedure for content uniformity in the monograph by finely powdering tablets or mixing
the contents of capsules or oral solutions, suspensions, emulsions, gels, or solids in single-unit
containers to obtain a homogeneous mixture. If a homogeneous mixture cannot be obtained in
this manner, use suitable solvents or other procedures to prepare a solution containing all of the
drug substance, and use appropriate aliquot portions of this solution for the specified procedures.
2.Assay separate, accurately measured portions of the composite specimen of capsules or tablets
or suspensions or inhalations or solids in single-unit containers, both (a) as directed in the Assay,
and (b) using the special Procedure for content uniformity in the monograph.
3.Calculate the weight of drug substance equivalent to 1 average dosage unit, by (a) using the
results obtained by the Assay procedure, and by (b) using the results obtained by the special
procedure.
4.Calculate the correction factor, F, by the formula:
F = W/P in which W is the weight of drug substance equivalent to 1 average dosage unit obtained
by the Assay procedure, and P is the weight of drug substance equivalent to 1 average dosage
unit obtained by the special procedure. If F is greater than 10, the use of a correction factor is not
valid.
5.The correction factor is to be applied only if F is not less than 1.030 nor greater than 1.100, or
not less than 0.900 nor greater than 0.970. If F is between 0.970 and 1.030, no correction is
required.
6.If F lies between 1.030 and 1.100, or between 0.900 and 0.970, calculate the weight of drug
substance in each dosage unit by multiplying each of the weights found using the special
procedure by F.
Uncoated, Coated, or Molded Tablets, Capsules, Oral Solutions in Single-Unit Containers, Oral
Suspensions or Oral Emulsions or Oral Gels in Single-Unit Containers, and Solids (including
Sterile Solids) in Single-Unit Containers Assay 10 units individually as directed in the Assay
in the individual monograph, unless otherwise specified in the Procedure for content uniformity
in the individual monograph. Calculate the acceptance value.
.
WEIGHT VARIATION
no dosage unit result can be less than (1 L2*0.01)M, while on the high side no dosage unit
result can be greater than (1 + L2*0.01)M. (This is based on an L2 value of 25.0.)
otherwise specified in the individual monograph
Suppositories, Transdermal Systems, and Inhalations Packaged in Premetered Dosage Units
[NOTEAcceptance value calculations are not required for these dosage forms.] Assay 10 units
individually as directed in the Assay in the individual monograph, unless otherwise specified in
the Procedure for content uniformity.
Select not fewer than 30 dosage units, and proceed as follows for the dosage form designated.
The result of the Assay, obtained as directed in the individual monograph, is designated as result
A, expressed as % of label claim (see Calculation of Acceptance Value). Assume that the
concentration (weight of drug substance per weight of dosage unit) is uniform. [NOTE
Specimens other than these test units may be drawn from the same batch for assay
determinations.]
Uncoated or Film-Coated Tablets Accurately weigh 10 tablets individually. Calculate the drug
substance content, expressed as % of label claim, of each tablet from the weight of the individual
tablet and the result of the Assay. Calculate the acceptance value.
Hard Capsules Accurately weigh 10 capsules individually, taking care to preserve the identity
of each capsule. Remove the contents of each capsule by a suitable means. Accurately weigh the
emptied shells individually, and calculate for each capsule the net weight of its contents by
subtracting the weight of the shell from the respective gross weight. Calculate the drug substance
content, expressed as % of label claim, of each capsule from the net weight of the individual
capsule content and the result of the Assay. Calculate the acceptance value.